Edition:
United States

Cancer Genetics Reports Q1 Loss Per Share Of $0.90


Monday, 20 May 2019 05:01pm EDT 

May 20 (Reuters) - Cancer Genetics Inc ::CANCER GENETICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND PROVIDES STRATEGIC BUSINESS UPDATE.Q1 LOSS PER SHARE $0.90.Q1 REVENUE FELL 10.8 PERCENT TO $6.8 MILLION.CONTINUE TO WORK WITH RAYMOND JAMES ON A STRATEGIC TRANSACTION. 

Company Quote

0.1883
-0.0183 -8.86%
4:00pm EDT